| Therapy Category | Targeted Therapy, Antibody-Drug Conjugate, Her2-Directed Therapy |
|---|---|
| Protocols/Regimens | T-Dm1 Monotherapy, Adjuvant T-Dm1 After Neoadjuvant Therapy With Residual Disease |
| Primary Indications | Her2-Positive Breast Cancer, Including Residual Invasive Disease After Neoadjuvant Therapy And Metastatic Disease After Prior Her2-Directed Therapy |
| Cancer/Tumor Types | Breast Cancer |
| Salt / Active Composition | UJVIRA TRASTUZUMAB EMTANSINE |
| Strength / Dosage | 100 |
| Dosage Form | Injection |
| Prescription Required | Yes |